Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Vyas, Kaushal
- Drug Therapy in Peptic Ulcer Disease
Abstract Views :205 |
PDF Views:0
Authors
Affiliations
1 Department of Gastromedicine, Sheth V. S. Hospital and N.H.L. Muni. Medical College, Ahmedabad, IN
1 Department of Gastromedicine, Sheth V. S. Hospital and N.H.L. Muni. Medical College, Ahmedabad, IN
Source
The Indian Practitioner, Vol 71, No 2 (2018), Pagination: 25-29Abstract
Peptic ulcer disease is a common GI disorder. In the last few decades infection with H. Pylori was associated with most ulcers in duodenum. NSAIDs use is another common cause for peptic ulcers. With advent of effective anti-secretory drugs and antibiotic regimen against H. Pylori, complete cure of peptic ulcer is possible in majority of cases. Antacids were initially used for ulcer diseases, which is now replaced almost completely by proton pump inhibitor (PPI). PPI remains the mainstay of therapy in uncomplicated peptic ulcer in addition to treating H. Pylori infection when present. Histamin-2 receptor antagonist (H2RA) and muco-protective agents are used in selective cases. Use of non NSAID analgesics and identifying high risk group patients on long term aspirin can minimize peptic ulcer disease. Role of diet in inducing or treating peptic ulcer disease remains controversial at best. Endoscopy remains the investigation of choice for diagnosis of peptic ulcer, as it also allows biopsy for H. Pylori and from suspicious area as well. Complications like bleeding and mortality from peptic ulcer disease also has decreased over time due to effective treatment strategies.References
- Management of Helicobacter pylori infection— The Maastricht IV/Florence Consensus Report. Malfertheiner P, Megraud F, O’Morain CA, et al. Gut 2012; 61:646-64.
- The prevalence and incidence of Helicobacter pyloriassociated peptic ulcer disease and upper gastrointestinal bleeding throughout the world. Wang AY, Peura DA. Gastrointest Endosc Clin N Am 2011; 21:613-35.
- Role of dietary polyphenols in the management. Farzaei MH, Abdollahi M, Rahimi R. of peptic ulcer. World J Gastroenterol 2015; Jun 7, 21:6499-517.
- Proton Pump Inhibitors: Review of Emerging Concerns. Nehra AK, Alexander JA, Loftus CG, Nehra V. Mayo Clin Proc. 2018; Feb; 93(2):240-246.
- Vonoprazan: A Novel and Potent Alternative in the Treatment of Acid-Related Diseases. Yang X, Li Y, Sun Y, et al. Dig Dis Sci. 2018 Feb; 63(2):302-311.
- Sleisenger and Fordtran’s Gastrointestinal and Liver diease. 10th Edition, 2016. Chapter 53. Peptic ulcer disease.
- Peptic ulcer disease. Lanas A, Chan FKL. Lancet 2017; Aug; 390:613-624.
- Management of Acute Upper Gastrointestinal Bleed
Abstract Views :194 |
PDF Views:1
Authors
Affiliations
1 Department of Gastromedicine, Sheth V. S. Hospital and N.H.L. Municipal Medical College, Ahmedabad, Gujarat, IN
1 Department of Gastromedicine, Sheth V. S. Hospital and N.H.L. Municipal Medical College, Ahmedabad, Gujarat, IN
Source
The Indian Practitioner, Vol 71, No 6 (2018), Pagination: 40-41Abstract
Acute upper GI bleed is a common emergency in gastrointestinal practice. In primary clinic setup these patients can be managed initially for stabilizing them clinically and transferring them to speciality center for further management.References
- Sleisnger and Fordtran Gastointestinal and liver disease, 10th edition.
- Irritable Bowel Syndrome (IBS) – a Family Physician’s Perspective
Abstract Views :173 |
PDF Views:0
Authors
Affiliations
1 Dept. of Gastromedicine, V.S. Hospital, Ahmedabad, IN
1 Dept. of Gastromedicine, V.S. Hospital, Ahmedabad, IN
Source
The Indian Practitioner, Vol 71, No 12 (2018), Pagination: 29-32Abstract
IBS is one of the commonest diagnoses made in OPD practice of a GI physician. Even primary care physicians encounter such patients very frequently in their day to day practice. Abdominal pain associated with altered bowel habit is a characteristic feature of this disorder. IBS is a clinical diagnosis, and many diagnostic criteria are available. IBS is sub-grouped as diarrhoea predominant, constipation predominant and mixed type. The exact cause of IBS is not certain. However, many factors including genetic predisposition to psychological stress is implicated. Most investigations ordered in IBS patients are to rule out other serious underlying diseases, and in majority of the cases, they are superfluous. The treatment options available are mainly symptomatic, and that’s why tailor-made therapy is required in each patient. There are numerous pharmacological and non-pharmacological options, which give significant benefit to the patients of IBS in symptom relief if used judiciously. Disease modifying therapy for IBS is not available currently, so the “cure” for the disease is not feasible with current medications.References
- IBS in general practice. W G Thompson et al. Gut 2000: 46:78-82
- Sleisenger and Fordtran, Gastrointestinal and Liver disease, 9th Edition.
- Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV. Drossman DA, Gastroenterology 2016;150:1262–1279.
- Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. Lacy BE, Patel N. J. Clin. Med. 2017, 6, 99.